Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery

Ronnie H. Fang; Che-Ming J. Hu; Brian T. Luk; Weiwei Gao; Jonathan A. Copp; Yiyin Tai; Derek E. O’Connor; Liangfang Zhang

doi:10.1021/nl500618u

journal article Mar 28, 2014

Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery

Ronnie H. Fang

Che-Ming J. Hu Brian T. Luk Weiwei Gao

Jonathan A. Copp Yiyin Tai Derek E. O’Connor Liangfang Zhang

Nano Letters Vol. 14 No. 4 pp. 2181-2188 · American Chemical Society (ACS)

View at Publisher Save 10.1021/nl500618u

Topics

No keywords indexed for this article. Browse by subject →

References

50

[1]

Davis M. E. Nat. Rev. Drug Discovery (2008) 10.1038/nrd2614

[2]

Nanocarriers as an emerging platform for cancer therapy

Dan Peer, Jeffrey M. Karp, Seungpyo Hong et al.

Nature Nanotechnology 2007 10.1038/nnano.2007.387

[3]

Moon J. J. Adv. Mater. (2012) 10.1002/adma.201200446

[4]

Yoo J. W. Nat. Rev. Drug Discovery (2011) 10.1038/nrd3499

[5]

Fang R. H. Expert Opin. Biol. Ther. (2012) 10.1517/14712598.2012.661710

[6]

Hu C. M. J. Adv. Healthcare Mater. (2012) 10.1002/adhm.201200138

[7]

Role of CD47 as a Marker of Self on Red Blood Cells

Per-Arne Oldenborg, Alex Zheleznyak, Yi-Fu Fang et al.

Science 2000 10.1126/science.288.5473.2051

[8]

Rodriguez P. L. Science (2013) 10.1126/science.1229568

[9]

Schwartzentruber D. J. New Engl. J. Med. (2011) 10.1056/nejmoa1012863

[10]

Hamdy S. Vaccine (2008) 10.1016/j.vaccine.2008.07.035

[11]

Xu Z. J. Controlled Release (2013) 10.1016/j.jconrel.2013.08.021

[12]

Hu C. M. Proc. Natl. Acad. Sci. U.S.A. (2011) 10.1073/pnas.1106634108

[13]

Hu C. M. J. Nanoscale (2013) 10.1039/c3nr00015j

[14]

Blonder J. Nat. Protoc. (2006) 10.1038/nprot.2006.359

[15]

McCarthy S. A. Nat. Protoc. (2012) 10.1038/nprot.2012.082

[16]

Furman N. E. T. Nano Lett. (2013) 10.1021/nl401376w

[17]

Parodi A. Nat. Nanotechnol. (2013) 10.1038/nnano.2012.212

[18]

Hu C. M. J. Nat. Nanotechnol. (2013) 10.1038/nnano.2013.54

[19]

Hu C. M. Nat. Nanotechnol. (2013) 10.1038/nnano.2013.254

[20]

Glinsky V. V. Cancer Res. (2003)

[21]

Khaldoyanidi S. K. J. Biol. Chem. (2003) 10.1074/jbc.m209590200

[22]

Hu C. M. Nanoscale (2014) 10.1039/c3nr05444f

[23]

Fang R. H. Langmuir (2010) 10.1021/la103576a

[24]

Luk B. T. Nanoscale (2014) 10.1039/c3nr06371b

[25]

Kim J. A. Nat. Nanotechnol. (2012) 10.1038/nnano.2011.191

[26]

Gratton S. E. A. Proc. Natl. Acad. Sci. U.S.A. (2008) 10.1073/pnas.0801763105

[27]

Mata-Haro V. Science (2007) 10.1126/science.1138963

[28]

Tamura Y. Science (1997) 10.1126/science.278.5335.117

[29]

Overwijk W. W. J. Exp. Med. (2003) 10.1084/jem.20030590

[30]

Frankenburg S. Immunol. Lett. (2004) 10.1016/j.imlet.2004.05.014

[31]

Kuwabara I. J. Immunol. (1996) 10.4049/jimmunol.156.10.3939

[32]

Degiovanni C. Int. J. Cancer (1994) 10.1002/ijc.2910590220

[33]

Kantoff P. W. New Engl. J. Med. (2010) 10.1056/nejmoa1001294

[34]

Di Pucchio T. Cancer Res. (2006) 10.1158/0008-5472.can-05-3396

[35]

Lollini P. L. Nat. Rev. Cancer (2006) 10.1038/nrc1815

[36]

Harrison C. Nat. Rev. Drug Discovery (2009) 10.1038/nrd3072

[37]

Lokhov P. G. J. Cancer (2010) 10.7150/jca.1.230

[38]

Pulido J. Nat. Biotechnol. (2012) 10.1038/nbt.2157

[39]

Castle J. C. Cancer Res. (2012) 10.1158/0008-5472.can-11-3722

[40]

Reddy S. T. Nat. Biotechnol. (2007) 10.1038/nbt1332

[41]

Schoenborn J. R. Adv. Immunol. (2007) 10.1016/s0065-2776(07)96002-2

[42]

Guy B. Nat. Rev. Microbiol. (2007)

[43]

Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses

James J. Moon, Heikyung Suh, Anna Bershteyn et al.

Nature Materials 2011 10.1038/nmat2960

[44]

Ruoslahti E. J. Cell Biol. (2010) 10.1083/jcb.200910104

[45]

Petros R. A. Nat. Rev. Drug Discovery (2010) 10.1038/nrd2591

[46]

Hrkach J. Sci. Transl. Med. (2012) 10.1126/scitranslmed.3003651

[47]

Zhou H. J. Cell Biol. (1993) 10.1083/jcb.122.4.951

[48]

Iurisci I. Anticancer Res. (2009)

[49]

Glinsky V. V. Cancer Res. (2000)

[50]

Zetter B. R. Semin. Cancer Biol. (1993)

Cited By

1,354

Long circulating nanocarriers: achievements and shortcomings of biomimetic approaches

Maryam A. Shetab Boushehri · 2026

International Journal of Pharmaceut...

Leveraging nature’s nanocarriers: Translating insights from extracellular vesicles to biomimetic synthetic vesicles for biomedical applications

Yunxi Chen, Noélie Douanne · 2025

Science Advances

Fibroblasts‐specific p16INK4a exacerbates inflammageing‐mediated post‐infarction ventricular remodelling through interacting with STAT3 to regulate NLRP3 transcription

Xin Gu, Yingqiang Du · 2025

Clinical and Translational Medicine

Inflammation: a matter of immune cell life and death

Elizabeth C. Bender, Halah S. Tareq · 2025

npj Biomedical Innovations

Nanoparticle approaches for manipulating cytokine delivery and neutralization

Rui Wang, Luke J. Kubiatowicz · 2025

Frontiers in Immunology

Harnessing prazosin for tumors: Liposome hybrid nanovesicles activate tumor immunotherapy via autophagy inhibition

Xinyang Xuanyuan, Wenshang Liu · 2025

Biomaterials

Polymeric Nanoparticles for Drug Delivery

Maximilian A. Beach, Umeka Nayanathara · 2024

Chemical Reviews

Blood–Brain Barrier‐Penetrating and Lesion‐Targeting Nanoplatforms Inspired by the Pathophysiological Features for Synergistic Ischemic Stroke Therapy

Lu Tang, Yue Yin · 2024

Advanced Materials

Ultrasound‐Activated Piezoelectric Nanoparticles Trigger Microglia Activity Against Glioblastoma Cells

Margherita Montorsi, Carlotta Pucci · 2024

Advanced Healthcare Materials

Cell membrane-coated nanoparticles for targeting carcinogenic bacteria

Lei Sun, Dan Wang · 2024

Advanced Drug Delivery Reviews

Personalized nanovaccines for treating solid cancer metastases

TANG Feng, Jia Hu · 2024

Journal of Hematology & Oncolog...

A combination of a TLR7/8 agonist and an epigenetic inhibitor suppresses triple-negative breast cancer through triggering anti-tumor immune

Zhenzhen Jiang, Guangqing Cai · 2024

Journal of Nanobiotechnology

Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy

Qiang Lu, Dongquan Kou · 2024

Journal of Hematology & Oncolog...

Nanomedicine in cancer therapy

Dahua Fan, Yongkai Cao · 2023

Signal Transduction and Targeted Th...

Engineered tumor cell-derived vaccines against cancer: The art of combating poison with poison

Xinyi Zhang, Hengqing Cui · 2023

Bioactive Materials

Advances in nanomaterial-based targeted drug delivery systems

Xiaoxiao Cheng, Qirong Xie · 2023

Frontiers in Bioengineering and Bio...

Vesicular Antibodies: Shedding Light on Antibody Therapeutics with Cell Membrane Nanotechnology

Chenchen Zhao, Yuanwei Pan · 2023

Advanced Materials

Biologically inspired stealth – Camouflaged strategies in nanotechnology for the improved therapies in various diseases

Mohammad Imran, Vemana Gowd · 2023

International Journal of Pharmaceut...

Tumor-derived systems as novel biomedical tools—turning the enemy into an ally

Nimeet Desai, Pratik Katare · 2023

Biomaterials Research

The advances in nanomedicine for bone and cartilage repair

Kai Qiao, Lu Xu · 2022

Journal of Nanobiotechnology

Metrics

1,354

Citations

50

References

Details

Published: Mar 28, 2014
Vol/Issue: 14(4)
Pages: 2181-2188
License: View

Authors

R

Ronnie H. Fang